Pacific Edge’s APAC operations advancing towards profit with cancer test growth

Pacific Edge APAC business is advancing towards profitability on a direct-cost basis with a growing interest…
Diabetes concept

Entropy reports 50% remission in Phase 2 psychedelic trial for binge eating disorder

Entropy Neurodynamics says its Phase 2 trial of TRP-8803 delivered 50% remission in all treatment-resistant binge…
The Market Online Video

Syntara shows encouraging first signals it can impact the path to Parkinson’s

Syntara (ASX:SNT) has reported encouraging interim results from its Phase 2 study of SNT-4728, providing the first clinical evidence

Syntara reports encouraging early Parkinson’s trial results

Syntara has reported statistically significant reductions in brain inflammation in an early-stage Parkinson's disease study.

OncoSil Medical files for US FDA approval for specialist device

OncoSil Medical has hit a key milestone in its plans to commercialise its unique OncoSil device…

Algorae secures NSW Health hospital supply agreement through AlgoraeRx

Algorae Pharmaceuticals has secured a NSW Health standing offer arrangement through its AlgoraeRx division.

Memphasys secures exclusive $430K Thailand distribution deal for Felix sperm system

Memphasys (ASX:MEM) has signed a three-year Thailand distribution deal with IVF Envimed for its Felix sperm separation system.

Neuren Pharmaceuticals welcomes milestone approval for Daybu

Neuren Pharmaceuticals has received positive news for the proposed marketing of the Daybu treatment of Rett…

Osteopore wraps up recruitment into 3D printing support for cleft lip patients

Osteopore has completed recruitment of all five patients required for the clinical trial of paranasal augmentation…
Felix, an automated sperm separation device used in IVF, is grabbing growing international attention.

Memphasys secures UK market entry, accelerating commercial rollout

Memphasys has entered the U.K. fertility market with four IVF groups putting in commercial orders to…